

OBJECTIVES: To explore the hypothesis that obesity is associated with increased mortality and worse outcomes in children who are critically ill. METHODS: Secondary analysis of the Assessment of Worldwide Acute Kidney Injury, Renal Angina, and Epidemiology study, a prospective, multinational observational study. Patients between 3 months and 25 years across Asia, Australia, Europe, and North America were recruited for 3 consecutive months. Patients were divided into 4 groups (underweight, normal weight, overweight, and obese) on the basis of their BMI percentile for age and sex. RESULTS: A total of 3719 patients were evaluated, of whom 542 (14%) had a primary diagnosis of sepsis. One thousand fifty-nine patients (29%) were underweight, 1649 (44%) were normal weight, 423 (11%) were overweight, and 588 (16%) were obese. The 28-day mortality rate was 3.6% for the overall cohort and 9.1% for the sepsis subcohort and differed significantly by weight status (5.8%, 3.1%, 2.2%, and 1.8% for subjects with underweight, normal weight, overweight, and obesity, respectively, in the overall cohort [P,.001] and 15.4%, 6.6%, 3.6%, and 4.7% in the sepsis subcohort, respectively [P =.003]). In a fully adjusted model, 28-day mortality risk was 1.8-fold higher in the underweight group versus the normal weight group in the overall cohort and 2.9-fold higher in the sepsis subcohort. Patients who were overweight and obese did not demonstrate increased risk in their respective cohorts. Patients who were underweight had a longer ICU length of stay, increased need for mechanical ventilation support, and a higher frequency of fluid overload. CONCLUSIONS: Patients who are underweight make up a significant proportion of all patients in the PICU, have a higher short-term mortality rate, and have a more complicated ICU course. © 2020 by the American Academy of Pediatrics
| EMTREE medical terms: | acute kidney failureadolescentage distributionartificial ventilationAsiaAustraliabody massbody weightchildchild nutritionchildhood mortalitychildhood obesityclinical outcomecohort analysiscontrolled studycritically ill patientepidemiological dataEuropefemalehealth care organizationhumanhypervolemialength of staymajor clinical studymalemortality ratemortality riskNorth Americaobservational studypediatric intensive care unitpediatric patientpreschool childpriority journalprospective studyReviewrisk factorsecondary analysissepsissex differenceunderweighturogenital tract disease assessmentcardiovascular diseasechildhood obesityclinical trialcomorbiditycritical illnesshospital mortalityintensive caremetabolic disordermortalitymulticenter studyobesityrespiratory failurerisk factorunderweight |
|---|---|
| MeSH: | AdolescentBody Mass IndexBody WeightCardiovascular DiseasesChildChild, PreschoolComorbidityCritical CareCritical IllnessFemaleHospital MortalityHumansLength of StayMaleOverweightPediatric ObesityRespiration, ArtificialRespiratory InsufficiencyRisk FactorsSepsisThinnessWater-Electrolyte Imbalance |
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| National Institutes of Health See opportunities by NIH | NIH | |
| National Institute of Diabetes and Digestive and Kidney Diseases See opportunities by NIDDK | P50DK096418 | NIDDK |
| Cincinnati Children's Hospital Medical Center |
FUNDING: Supported by a grant from the National Institutes of Health (NIH P50 DK096418; to Drs Basu and Goldstein) from the Pediatric Nephrology Center of Excellence at Cincinnati Children’s Hospital Medical Center. Funded by the National Institutes of Health (NIH).
A complete list of investigators in the AWARE study is provided in the Supplemental Information. Supported by a grant from the National Institutes of Health (NIH P50 DK096418; to Drs Basu and Goldstein) from the Pediatric Nephrology Center of Excellence at Cincinnati Children's Hospital Medical Center. Funded by the National Institutes of Health (NIH).
Dr Kaddourah’s Pediatric Acute Care Nephrology and Dialysis Fellowship at Cincinnati Children’s Hospital Medical Center was supported by an educational grant from Gambro Renal Products.
Kaplan, J.M.; Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 7006, Cincinnati, OH, United States;
© Copyright 2020 Elsevier B.V., All rights reserved.